Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Predictive Oncology Inc. | Financial_Report.xls |
| 10-Q - FORM 10-Q - Predictive Oncology Inc. | v312956_10q.htm |
| EX-31.2 - EXHIBIT 31.2 - Predictive Oncology Inc. | v312956_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Predictive Oncology Inc. | v312956_ex31-1.htm |
Exhibit 32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of BioDrain Medical, Inc. (the “Company”) for the quarter ended March 31, 2012 as filed with the Securities and Exchange Commission (the “Report”), I, Joshua Kornberg, Interim Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer) of the Company, hereby certify as of the date hereof, solely for purposes of § 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1350, that to the best of my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
| Date: May 15, 2012 | /s/ Joshua Kornberg | |
| Joshua Kornberg | ||
| Interim Chief Executive Officer and Chief Financial Officer | ||